Ranbaxy news
Ambuja Cements, ACC, Maytas, Ranbaxy: India Stock Preview
Ambuja Cements, ACC, Maytas, Ranbaxy: India Stock Preview
Bloomberg - 11 minutes ago
By Anil Varma Nov. 13 (Bloomberg) -- The following companies may have unusual price changes in India trading. Stock symbols are in parentheses and share prices are from the last close, unless ...
Daiichi Sankyo to introduce Ranbaxy's generic drug in Japan
Daiichi Sankyo to introduce Ranbaxy's generic drug in Japan
Trading Markets - 46 minutes ago
Nov 12, 2009 (Datamonitor via COMTEX) -- RBXLF -- Japanese pharmaceutical group Daiichi Sankyo is all set to launch some of Ranbaxy Laboratories's generic medicine in the Japanese market shortly ...
Ranbaxy Laboratories Limited Gets WHO Approval For AIDS Drug-Reuters
Ranbaxy Laboratories Limited Gets WHO Approval For AIDS Drug-Reuters
Reuters Key Development - 1 hour ago
India's Ranbaxy gets WHO approval for AIDS drug
India's Ranbaxy gets WHO approval for AIDS drug
Reuters - 49 minutes ago
MUMBAI, Nov 12 (Reuters) - Ranbaxy Laboratories (RANB.BO), India's top drug maker by sales, said on Thursday it received the World Health Organization pre-qualification for its Indinavir anti ...
Nuvo research provides WF10 licensing and development update
Nuvo research provides WF10 licensing and development update
Canada NewsWire - 1 hour ago
MISSISSAUGA, ON, Nov. 11 /CNW/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the ...
Nuvo research provides WF10 licensing and development update
Nuvo research provides WF10 licensing and development update
SYS-CON Media - 4 minutes ago
MISSISSAUGA, ON , Nov. 11 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to ...
CLB to hear Ranbaxy plea on Friday
CLB to hear Ranbaxy plea on Friday
Economic Times - 28 minutes ago
NEW DELHI: The Company Law Board (CLB) will hear a complaint by Ranbaxy Laboratories, which is contesting the appointment of two independent directors on the board of Zenotech by the founder and ...
Reliance Natural, Ranbaxy and Kingfisher: India Equity Preview
Reliance Natural, Ranbaxy and Kingfisher: India Equity Preview
Bloomberg - 27 minutes ago
By Anil Varma and Rajhkumar K Shaaw Nov. 11 (Bloomberg) -- The following companies may have unusual price changes in India trading. Stock symbols are in parentheses and share prices are from the ...
TNPDA to approach Ranbaxy to settle Rs 3 cr worth credit notes issued by Ochoa Lab
TNPDA to approach Ranbaxy to settle Rs 3 cr worth credit notes issued by Ochoa Lab
pharmabiz.com - 43 minutes ago
Tamil Nadu Pharmaceutical Distributors Association (TNPDA) will soon approach Ranbaxy Laboratories Ltd to settle the cases of credit notes issued by Delhi based Ochoa Laboratories to the ...
